Hydrogel-based reinforcement of 3D bioprinted constructs 1. Introduction
In recent years, 3D bioprinting has emerged as a technology platform showing potential for initiating drastic advances in drug testing, disease models, tissue engineering and regenerative medicine [1] . Bioprinting often employs hydrogels, in this context termed bioinks, in combination with cells to produce complex shapes using 3D printing technologies [2] . Three-dimensional cell culture generally requires hydrogels having low polymer concentrations, low stiffness and low cross-linking densities, to allow unhindered solute diffusion, cell migration and proliferation, as well as deposition of newly formed extracellular matrix [3, 4] . On the other hand, hydrogels for 3D printing with high shape fidelity ideally have high viscosity and yield stress to allow for spatially accurate extrusion, as well as rapid gelation and sufficient mechanical stability to maintain the shape of the final (cross-linked) gel [5] .
Particularly for in vivo applications, mechanical stability is of utmost importance, and many of the employed bioinks lack sufficient mechanical properties [2] . One promising approach to overcome this hurdle is hybrid printing, in which the functions of mechanical support and cell encapsulation are separated into two materials. Most commonly, a bioink containing cells is co-printed with thermoplastics (ϵpolycaprolactone in particular) [6, 7, 8, 9, 10, 11] , or UV curing adhesive [12] . While effective in improving mechanical properties, these materials either need high temperatures for processing, and/or show poor interaction between hydrophilic and hydrophobic components. Furthermore, they allow limited control over the resulting mechanical properties, and importantly, over degradation kinetics. Particularly for the engineering of mechanically stable soft tissues, no ideal reinforcing material is currently available.
Here, we demonstrate a novel approach for the fabrication of mechanically stable biofabricated constructs, while maintaining control over degradation kinetics and mechanical properties. We aim to achieve this by separating the reinforcing and cell encapsulation functionalities into two distinct hydrogels: one with a high synthetic polymer concentration possessing excellent shape stability upon printing and one with a low natural polymer concentration exhibiting excellent cell encapsulation properties.
Materials and methods

Materials
Poloxamer 407 triblock copolymer was acquired from BASF (Ludwigshafen, Germany). D,L-lactide, L-lactide and glycolide were purchased from Corbion Purac (Gorinchem, The Netherlands). Irgacure 2959 was obtained from Ciba Specialty Chemicals (Basel, Switzerland). Solvents, unless indicated otherwise, were acquired from Biosolve (Valkenswaard, The Netherlands). Stannous octoate (Sn(Oct) 2 ), ϵ-caprolactone, triethylamine (TEA), deuterated chloroform (CDCl 3 ), methacrylic anhydride, gelatin (type A from porcine skin, 175 g bloom), calcein AM, ethidium homodimer and sodium azide were all provided by Sigma Aldrich (Zwijndrecht, The Netherlands). Dialysis membranes (Spectra/Por 2, upper molecular weight cutoff 12-14 kDa) were obtained from Carl Roth (Karlsruhe, Germany). Cartridges and extrusion nozzles for 3D printing were obtained from Nordson EFD (Maastricht, The Netherlands). Biopsy punches were acquired from Milltex (Zaventem, Belgium).
All percentages concerning solutions are presented as %w/w, unless stated otherwise.
Poloxamer macromers synthesis and characterization
Poloxamer 407 was first dried by azeotropic distillation with toluene using a Dean Stark apparatus and then chain-extended by ring opening polymerization of either ϵcaprolactone, D,L-lactide, or an equimolar mixture of L-lactide and glycolide for 1 to 2 days at 130 to 150 • C in the presence of Sn(Oct) 2 as a catalyst, under a nitrogen atmosphere. The resulting polymers, and poloxamer 407 itself, were then dissolved in dry dichloromethane at a concentration of 20% and their terminal hydroxyl groups were reacted with a 3 times excess of methacrylic anhydride in the presence of an amount of triethylamine equal to the amount of methacrylic anhydride added. During the reaction, samples were taken and their NMR spectra were recorded in CDCl 3 . When insufficient conversion was observed, another 3 times excess methacrylic anhydride and an equimolar amount of triethylamine were added to the reaction mixture. Purification was realized by precipitation from diethyl ether and drying under ambient conditions. The resulting macromonomers (macromers) are abbreviated as P-CL-MA, P-LA-MA and P-LG-MA, with ϵ-caprolactone, D,L-lactide or an L-lactide-co-glycolide oligoesters, respectively. The macromer not possessing any hydrolysable ester will be referred to as P-MA. The targeted block lengths for the terminal ester blocks were 1 repeating unit for caprolactone, 2 for D,L-lactide and a combined total of 4 for L-lactide-co-glycolide. Poloxamer macromers were analyzed using 1 H NMR (Varian 400 MHz), with samples dissolved in CDCl 3 . More detailed information on macromer composition, analysis and acronyms is available in the supporting info.
Gelatin methacryloyl synthesis and characterization
GelMA was synthesized by reacting gelatin with methacrylic anhydride, as reported previously [13] . For purposes of illustration, FITC-labeled gelMA was used to create pictures of samples where it would otherwise be difficult to discriminate between poloxamer gel and gelMA.
Rheological characterization
Reinforcing gels were prepared by dissolving modified and unmodified poloxamer 407 at 28.6% in PBS. Their flow behavior was analyzed using a DHR2 rheometer (TA Instruments, Etten-Leur, The Netherlands), equipped with a Peltier plate and 40 mm cone at a truncation gap of 54 µm. Viscosity as a function of temperature was measured by heating the plate from 4 to 45 • C at a rate of 5 • C min -1 . A shear rate of 100 s -1 was applied to approximate the shear rate experienced by gels in the nozzle of a 3D printer. Yield shear stress was measured by gradually increasing the torque from 0 to beyond the point where flow was observed. The stress value assigned to the yield stress was calculated by determining the peak value of the derivate of viscosity versus stress. Shear thinning behavior was measured by recording the viscosity as a function of shear rate from 0.1 to 630 s -1 at a temperature of 21 • C.
Construction of reinforced 3D printed gels
The reinforcing gel was prepared by adding P-MA to PBS at a concentration of 28.6% and was subsequently dissolved over 36 hours at 4 • C. GelMA was dissolved at a concentration of 5% in PBS at 37 • C for one hour. Both gel-precursors were supplemented with 0.1% Irgacure 2959.
CAD-models of various anatomical objects were translated into g-code using MMconverter (regenHU, Villaz-St-Pierre, Switzerland). Alternatively, samples for the analysis of printed construct stiffness were created by manually drawing the printer path in vector graphics and translating this into g-code using BioCAD (regenHU, Villaz-St-Pierre, Switzerland). In both cases, the produced g-code can be read and executed on a 3DDiscovery bioprinter (regenHU, Villaz-St-Pierre, Switzerland). The bioprinter was provided with two cartridges. One was filled with the reinforcing gel and the other filled with the bioink. Print cartridges were kept at room temperature and 37 • C, respectively. Extrusion was air-pressure driven and for the reinforcing gel its pressure was set at 1.2 bar and 0.5 bar for the gelMA gel. Conical nozzles (27G) were used for deposition of reinforcing gel, whereas gelMA gels were deposited using a temperature controlled microvalve and nozzle (regenHU, Villaz-St-Pierre, Switzerland), with an inner diameter of 0.3 mm. Each deposited layer was illuminated for 10 seconds using a built-in UVled (λ = 365 nm, E = 240.2 mW cm -2 at h = 1 cm) and completely built samples were subjected to an additional 15 minutes post cross-linking using a Vilber Lourmat portable UV-lamp (λ = 365 nm, E = 3 mW cm -2 at h = 2 cm) (Hartenstein, Würzburg, Germany).
Different strand distances were used to create samples with varying weight ratios of P-MA reinforcing gel to gelMA bioink. The stiffness of these constructs was subsequently measured as described below in section 2.7.
Hydrolytic degradation of reinforcing gels
Macromers P-MA, P-CL-MA, P-LA-MA, P-LG-MA as well as a 1:1 mixture of P-LA-MA and P-CL-MA were dissolved in PBS at a concentration of 28.6% with 0.1% Irgacure 2959. Gel precursor solutions were obtained after 36 hours of dissolution at 4 • C, these were injected into molds and subsequently cross-linked using a UV cross-linker (CL-1000, λ = 365 nm, 10.9 mW cm -2 at h = 6 cm) (UVP, Cambridge, United Kingdom) for 15 minutes to yield disks with a diameter and height of 6 and 2 mm, respectively. To study degradation, gels were placed in 50 ml PBS supplemented with 0.02% sodium azide to prevent bacterial growth and stored at 37 • C.
Mechanical characterization
Printed gel squares were cut to similar size as the molded gels using a 6 mm diameter biopsy punch. Both printed and samples were then subjected to uniaxial, unconfined compression at a strain rate of 30% min -1 between two parallel plates using a Q800 dynamical mechanical analyzer (TA Instruments, Etten-Leur, The Netherlands), up to 20% strain. Stiffness of the printed samples and Youngs modulus of the cast gels was calculated from the slope of the stress-strain curve between 3 and 10% strain.
Cell viability
Equine chondrocytes were suspended at a concentration of 1 · 10 6 cells ml -1 in a 5% gelMA solution at 37 • C. This cellularized bioink was then printed up to two layers high, with P-MA as a reinforcing gel and using similar settings as those used to obtain samples for tuning the stiffness. Constructs were cultured for 24 hours and subsequently calcein AM was used to label live cells and ethidium homodimer to label dead cells. Cells labeled both red and green were counted as being alive. 
Results & Discussion
Poloxamer macromer synthesis and characterization
Building on previous work [14] , we have developed printable hydrogels based on modified poloxamer 407. These triblock copolymers were chain-extended with α-hydroxy acids and methacrylate moieties, yielding 3 different hydrolysable macromonomers. Additionally, a non-degradable variant was also synthesized that does not possess an oligoester spacer. In aqueous environments, these macromers exhibit a lower critical solution temperature (LCST). At temperatures below the LCST, the PPG segments are hydrated, while at elevated temperatures they dehydrate and aggregate, resulting in the entropy-driven formation of micelles. Above the critical aggregation concentration (CAC) and LCST, the PEG coronas start to overlap and entangle, resulting in the formation of a highly viscous physical gel [15] . Modified poloxamer 407 gels exhibit shear thinning behavior when the imposed shear stress exceeds the yield shear stress, as occurs in the nozzle of a 3D printer [13] . We selected a reinforcing gel concentration of 28.6% (0.4 g per ml solvent), which is above the CAC [15] and was found to be sufficient for 3D printing application, while yielding stiff gels with rubber-like appearance after cross-linking under ambient conditions.
Rheological characterization
The modified poloxamer-based hydrogels exhibit a nearly identical shear thinning behavior, when compared to gels based on unmodified poloxamer, as shown in figure 2a . From figure 2b and c it is also apparent that modified poloxamer based gels also possess a yield stress and temperature dependent viscosity. Interestingly, P-CL-MA based hydrogels exhibit a higher yield stress than the other 4 gel compositions.
Construction of reinforced 3D printed gels
As can be seen from figure 3, the hybrid 3D bioprinting approach proposed allows for the generation of complex shapes. The selected bioink was composed of 5% gelatin methacryloyl (gelMA), for its desirable properties for cell encapsulation [16, 17, 18, 19] . Previously, 3D printing of bioinks based on 10% gelMA was realized by addition of viscosity or gelation modifiers [13, 20] , or by strictly controlling temperature [17] . Here, a gelMA bioink with a concentration as low as 5% was deposited in-between strands of P-MA reinforcing gel, building a 3D construct up 10 mm high. To demonstrate the improved control over printed geometry, also a more challenging shape was produced, resembling the auricular cartilage. This hybrid bioprinting approach allows control over the mechanical properties of the construct within a specific range, by altering the composition of the 3D print. Specifically, this can be achieved by increasing or decreasing the distance between adjacent strands of the reinforcing gel, thus influencing the weight ratio of reinforcing gel with respect to the bioink in the printed construct. This approach resulted in the ability to tailor the overall stiffness of printed gel constructs. For instance, a strand spacing of 2.7 mm yielded a stiffness of 138 ± 25 kPa, while decreasing this distance to 1.35 mm increased the overall stiffness about two fold to 263 ± 48 kPa, as can be seen from figure 4 . The achieved stiffness demonstrated here is considerably lower than that of samples reinforced using thermoplastics such as polycaprolactone, which exhibit stiffness values up to several MPa [9, 21] . For this reason, reinforcing gels may be particularly advantageous for the bioprinting of soft tissues, for which currently very few options for reinforcing exist.
Cell viability
To demonstrate the cytocompatibility of this hybrid bioprinting approach, equine chondrocytes embedded within a 5% gelMA gel were co-printed with P-MA reinforcing gel into a hybrid construct. After 24 hours in culture, calcein staining showed that over 90% of the encapsulated cells were viable, as represented in figure 5 . These findings are indicating that the printing process had a limited effect on cell viability.
Hydrolytic degradation of reinforcing gels
Regenerative approaches aim to fully restore the tissue which means that over time, the implanted material should be cleared from the body and its function taken over by newly formed tissue [22] . This requires a precise control over the timing and mechanism of scaffold degradation. However, not all currently investigated printable biomaterials allow fine-tuning of their degradation kinetics. Because of the flexibility of the modified poloxamer macromer platform, a broad range of degradation rates could be realized. Based on a principle first demonstrated by Hubbell in 1993 for poly(ethylene glycol) based hydrogels, incorporation of a degradable oligoester spacer between poloxamer and methacrylate moiety allows degradation of cross-linked hydrogels obtained from these macromers to be tuned as desired [23] . Considering figure 6 it can be seen that upon incubation in PBS at 37 • C, gel disks prepared from P-LG-MA macromers show a rapid decline in stiffness within the first week and fully dissociate within 2 weeks. On the contrary, P-CL-MA gels exhibit limited loss of structural integrity even after 40 weeks. Since poloxamer-oligoester based gels degrade via bulk degradation, mass loss of the hydrated gel is negligible up to the point where no covalent crosslinks remain. Beyond this point, gels disintegrate and dissolve rapidly [24] . All gels tested in this study, except those composed of P-MA, show a decline in Youngs modulus over time.
Conclusion
In order for a biofabrication strategy to be successful, it should fulfill both biological and mechanical aspects to an optimal extent. We have presented here a novel approach that can contribute towards the bioprinting of mechanically stable soft tissues, by separating these two functions into two different and specialized hydrogels. This has resulted in a strategy that allows for accurate control over mechanical properties and degradation kinetics. Finally, we would like to highlight the potential of this technique by mentioning it may also find application in other areas of research currently utilizing hydrogels, such as soft robotics [25] , biosensors [26, 27] and artificial organs [28, 1] , but foremost in tissue engineering, where it may contribute to the manufacturing of implantable, mechanically stable functional tissues. 
